We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
+14.14%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$94.3B
AUM Growth
+$7.96B
Cap. Flow
-$2.37B
Cap. Flow %
-2.52%
Top 10 Hldgs %
12.56%
Holding
2,315
New
140
Increased
934
Reduced
1,002
Closed
155

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$335M
2
EXC icon
Exelon
EXC
+$314M
3
PG icon
Procter & Gamble
PG
+$241M
4
TRIP icon
TripAdvisor
TRIP
+$208M
5
SBUX icon
Starbucks
SBUX
+$182M

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$551M
2
TGT icon
Target
TGT
+$514M
3
CELG
Celgene Corp
CELG
+$495M
4
CI icon
Cigna
CI
+$369M
5
COST icon
Costco
COST
+$310M

Sector Composition

Rank Sector Weight
1 Technology 19.77%
2 Healthcare 19.09%
3 Consumer Discretionary 13.69%
4 Industrials 9.28%
5 Financials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDMO
2126
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$116K ﹤0.01%
27,286
VSTM icon
2127
Verastem
VSTM
$610M
$114K ﹤0.01%
3,202
-1,544
-33% -$61K
VSA
2128
VisionSys AI
VSA
$10.6M
$112K ﹤0.01%
8
GCAP
2129
DELISTED
Gain Capital Holdings, Inc.
GCAP
$112K ﹤0.01%
17,832
+244
+1% +$1.62K
TTOO
2130
DELISTED
T2 Biosystems, Inc
TTOO
$111K ﹤0.01%
8
SVRA icon
2131
Savara
SVRA
$1.19B
$110K ﹤0.01%
14,983
-3,138
-17% -$23.6K
SENS icon
2132
Senseonics Holdings Inc
SENS
$366M
$102K ﹤0.01%
2,089
-1,239
-37% -$65.9K
ATHX
2133
DELISTED
Athersys, Inc. Common Stock
ATHX
$102K ﹤0.01%
2,729
UPL
2134
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$102K ﹤0.01%
+166,487
New +$121K
ABUS icon
2135
Arbutus Biopharma
ABUS
$915M
$101K ﹤0.01%
28,128
-93,514
-77% -$359K
ARDX icon
2136
Ardelyx
ARDX
$997M
$98K ﹤0.01%
35,076
-104,954
-75% -$273K
SHYF
2137
DELISTED
The Shyft Group
SHYF
$98K ﹤0.01%
11,153
-21,366
-66% -$182K
FRTA
2138
DELISTED
Forterra, Inc
FRTA
$96K ﹤0.01%
22,783
SIEN
2139
DELISTED
Sientra, Inc.
SIEN
$95K ﹤0.01%
1,111
-471
-30% -$52.7K
EGO icon
2140
Eldorado Gold
EGO
$9.89B
$89K ﹤0.01%
+19,251
New +$74.9K
DHT icon
2141
DHT Holdings
DHT
$3.02B
$88K ﹤0.01%
+19,634
New +$84.2K
RLH
2142
DELISTED
Red Lions Hotel Corporation
RLH
$88K ﹤0.01%
10,911
GNMK
2143
DELISTED
GenMark Diagnostics, Inc
GNMK
$84K ﹤0.01%
+11,807
New +$77.8K
NERV icon
2144
Minerva Neurosciences
NERV
$199M
$81K ﹤0.01%
1,285
-758
-37% -$45.6K
MRNS
2145
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$79K ﹤0.01%
+4,712
New +$67.8K
SNDX icon
2146
Syndax Pharmaceuticals
SNDX
$1.82B
$74K ﹤0.01%
+14,117
New +$80.5K
VRN
2147
DELISTED
Veren
VRN
$73K ﹤0.01%
22,550
-70,537
-76% -$217K
VATE icon
2148
INNOVATE Corp
VATE
$165M
$71K ﹤0.01%
2,886
ACH
2149
Accendra Health
ACH
$214M
$67K ﹤0.01%
16,326
-10,155
-38% -$64.2K
BAS
2150
DELISTED
Basis Energy Services, Inc.
BAS
$64K ﹤0.01%
16,721
-5,941
-26% -$29K

Similar funds

AQR Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, AQR Capital Management held 2,315 positions worth $94.3B, up 9.2% from $86.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

AQR Capital Management's Q1 2019 filing shows 140 new, 934 increased, 1,002 reduced and 155 closed positions. Its largest new stake was Canopy Growth: 121,700 shares worth $52.7M. The largest sale was Walmart Inc, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • AQR Capital Management's largest Q1 2019 buy was Canopy Growth: 121,700 shares worth $52.7M.
  • AQR Capital Management added most to Biogen in Q1 2019, an estimated $335M increase.
  • AQR Capital Management's biggest Q1 2019 reduction was Walmart Inc, cutting an estimated $551M.
  • AQR Capital Management fully exited Dun & Bradstreet in Q1 2019, selling an estimated $74.4M.
  • AQR Capital Management's ten largest holdings make up 13% of its $94.3B portfolio in Q1 2019.
  • AQR Capital Management opened 140 new positions and closed 155 in Q1 2019.
  • AQR Capital Management's portfolio value rose 9.2% quarter-over-quarter to $94.3B.

Based on AQR Capital Management's 13F filing for Q1 2019, filed 14 May 2019.